Tomoko Kodaka

Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor

Takayuki Sugiura, Sachiko Kondo, Seishi Kishimoto et al. · Journal of Biological Chemistry · 2000 · 371 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor

Takayuki Sugiura, Tomoko Kodaka, Shinji Nakane et al. · Journal of Biological Chemistry · 1999 · 313 citations · Full text

Medicine, Neuroscience, Pharmacology +14

2-Arachidonoylglycerol, a Putative Endogenous Cannabinoid Receptor Ligand, Induces Rapid, Transient Elevation of Intracellular Free Ca2+in Neuroblastoma × Glioma Hybrid NG108-15 Cells

Takayuki Sugiura, Tomoko Kodaka, Sachiko Kondo et al. · Biochemical and Biophysical Research Communications · 1996 · 167 citations

Life Sciences, Neuroscience, Pharmacology +11

2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca²⁺‐dependent and ‐independent mechanisms

Sachiko Kondo, Hironori Kondo, Shinji Nakane et al. · FEBS Letters · 1998 · 147 citations

Medicine, Biochemistry, Pharmacology +12

Detection of an Endogenous Cannabimimetic Molecule, 2-Arachidonoylglycerol, and Cannabinoid CB1 Receptor mRNA in Human Vascular Cells: Is 2-Arachidonoylglycerol a Possible Vasomodulator?

Takayuki Sugiura, Tomoko Kodaka, Shinji Nakane et al. · Biochemical and Biophysical Research Communications · 1998 · 145 citations

Medicine, Pharmacology, Cell Signaling +9